HIV/AIDS News

Indian children living with HIV showed significant weight and height improvements with antiretroviral therapy when it commenced before 5 years of age, according to the results of retrospective cohort analysis presented at the 2013 International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Kuala Lumpur, Malaysia.

HIV-infected children are surviving into adulthood because of antiretroviral therapy, and optimal health care for these patients includes a plan for transition into adult health care, according to a recent AAP policy statement published in Pediatrics.

HIV-infected children are surviving into adulthood because of antiretroviral therapy, and optimal health care for these patients includes a plan for transition into adult health care, according to a recent AAP policy statement published in Pediatrics.

Specialized psychosocial support interventions significantly improved treatment retention among adolescents on antiretroviral treatment, according to study results presented at the 2013 International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Kuala Lumpur.

Once-daily atazanavir powder with ritonavir liquid plus optimized nucleoside reverse transcriptase inhibitor background therapy was effective and well tolerated in HIV-infected children who were antiretroviral therapy naive or ART experienced, according to study results presented at the 2013 International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Kuala Lumpur, Malaysia.

Once-daily atazanavir powder with ritonavir liquid plus optimized nucleoside reverse transcriptase inhibitor background therapy was effective and well tolerated in HIV-infected children who were antiretroviral therapy naive or ART experienced, according to study results presented at the 2013 International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Kuala Lumpur, Malaysia.

Maraviroc plus optimized background therapy in HIV-infected children appeared well tolerated and effective, according to study results presented at the 2013 International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Lumpur, Malaysia.

Maraviroc plus optimized background therapy in HIV-infected children appeared well tolerated and effective, according to study results presented at the 2013 International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Lumpur, Malaysia.

Maraviroc plus optimized background therapy in HIV-infected children appeared well tolerated and effective, according to study results presented at the 2013 International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Lumpur, Malaysia.

WHO issued new HIV treatment guidelines during the opening day of the 2013 International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Kuala Lumpur, Malaysia, that recommend offering antiretroviral therapy earlier.